Maze Therapeutics receives positive ratings following recent IPO
Investing.com -- Maze Therapeutics Inc (NASDAQ: MAZE ) received bullish coverage from multiple analysts, with Guggenheim, ...
reinsurancene17 小时
S&P revises AXA’s outlook to positive, affirms key ratings
S&P Global Ratings, a provider of credit ratings, research, and risk analysis, has revised its outlook on AXA Group, an ...